Investor Relations

Sun BioPharma Inc. is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Sun BioPharma has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, AZ, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma’s common stock is quoted on the OTCQB tier of the over-the-counter markets administered by OTC Markets Group, Inc. under the symbol SNBP.

Sign up to receive press releases via email

Press Releases

 

Events & Presentations

 

Corporate Governance

Sun BioPharma has adopted a code of business conduct and ethics regarding the conduct of all executive and other officers, employees and agents. It is our policy to comply strictly with all laws governing our operations and to conduct our affairs in keeping with the highest moral, legal and ethical standards.

Audit Committee Charter
Code of Business Conduct and Ethics
Compensation Committee Charter
Disclosure Policy
Insider Trading Policy
Nominating and Governance Committee Charter
Related Person Transaction Approval Policy
Whistleblower Policy

Committee Composition
Independent DirectorsAuditCompensationNominating & Governance
Dalvir S. Gill, PhDX
Jeffrey S. MathiesenCX
J. Robert Paulson, Jr.XC
Paul W. SchafferXX
D. Robert SchemelXC

C = Chair   X = Member

Stock Transfer Agent and Registrar

VStock Transfer, LLC acts as transfer agent and registrar for Sun BioPharma and maintains all shareholder records for the company. Should you have questions regarding the Sun BioPharma stock you own, stock transfers, or address or name changes, please contact VStock Transfer by writing or calling:

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Toll-Free: (855) 9VSTOCK
Fax: (646) 536-3179
Email: info@vstocktransfer.com

Independent Auditors: Cherry Bekaert
401 East Jackson St, Suite 3400
Tampa, FL 33602
Phone: (813)-251-1010
Fax: (813) 251-9235

 

Leadership

Company Management

David B. Kaysen, President, Chief Executive Officer
Michael T. Cullen, M.D., MBA, Co-Founder, Executive Chairman
Scott Kellen, Vice President and Chief Financial Officer
Thomas X. Neenan, Ph.D., Co-Founder and Chief Scientific Officer
Suzanne Gagnon, M.D., Chief Medical Officer
Ajit Shah, Ph.D., VP Pharmacology
Tammy Groene, Vice President of Operations and Corporate Secretary
Anthony L. Kiorpes, Ph.D., DVM, Toxicology Consultant
Michael Walker, M.D., Director of Pancreatic Research

Board of Directors

Michael T. Cullen, M.D., MBA, Co-Founder, Executive Chairman
David B. Kaysen, President, Chief Executive Officer
Robert Schemel, Chairman of the Compensation Committee and Member of the Nominating and Corporate Governance Committee
Paul W. Schaffer, PharmD, Member of the Compensation and Audit Committee
J. Robert Paulson, Jr., MBA, Chairman of the Nominating and Corporate Governance Committee and Member of Audit, Compensation Committee
Jeff Mathiesen, Chairman of the Audit Committee, Member of the Nominating and Corporate Governance Committee
Suzanne Gagnon, M.D., Chief Medical Officer
Dalvir Gill, Ph.D.

 

Financial Information

 

Contact Us

EVC Group

Investor Relations Contact:
Doug Sherk: (415) 652-9100
Michael Polyviou: (212) 850-6020

Media Contact:
Dave Schemelia: (646) 201-5431

Sun BioPharma

(952) 479-1196
bd@sunbiopharma.com